8:00-10:00
(1) EADO SESSION
Question about prevention and early detection of melanoma
Chairs: Ketty Peris (Italy),Antonio Ribas (USA), Marie-Aleth Richard (France) |
| 8:00 |
Prevention
|
8:20 |
|
| 8:40 |
Early detection and surveillance of nevi |
| 9:00 |
|
| 9:20 |
|
| 9:40 |
- Kinetics of melanoma growth: an impact on early detection?
Jean-Jacques Grob (France)
|
10:30-12:30
(2) ICATMM SESSION
Adjuvant therapy: what have we learnt?
Sponsored by an educational grant from GlaxoSmithKline
Chairs: Brigitte Dreno (France), John M. Kirkwood (USA), Spyros Retsas (United Kingdom) |
| 10:30 |
How can we select subgroups for adjuvant therapy? |
| 10:50 |
|
| 11:10 |
|
| 11:30 |
|
| 11:50 |
|
| 12:10 |
- Detection of residual disease during surveillance: imaging and ultrasound
Philippe Saiag (France)
|
14:30-15:50
(2)ICATMM SESSION
Adjuvant therapy: what have we learnt?
Sponsored by an educational grant from GlaxoSmithKline
Chairs: Sanjiv S.Agarwala (USA), Hubert Pehamberger (Austria), Philippe Saiag (France) |
| 14:30 |
Current status of the adjuvant therapy
|
| 14:50 |
|
| 15:10 |
- Twenty years of adjuvant therapy studies with Interferon alpha, who benefits?
Alexander Eggermont (The Netherlands)
|
| 15:30 |
|
16:30-18:15
FREE ORAL COMMUNICATIONS 1
Chairs: Michael Binder (Austria), Jeffrey E. Gershenwald (USA), Peter Hersey (Australia) |
18:30-19:30
SATELLITE SYMPOSIUM jointly sponsored by the American Academy of CME and
North American Medical Education
Immunotherapy For Advanced Melanoma
Redefining Treatment Expectations
Chair: John Kirkwood (USA)
Speakers: Alexander Eggermont (The Netherlands), Patrick Hwu (USA), Caroline Robert (France), Dirk Schadendorf (Germany)
- Recent clinical trial evidence regarding immunotherapies including anti-CTLA-4 inhibitors
- Kinetics of anti-CTLA-4 inhibitors and relevance to treatment decision-making and monitoring of response
- Detection and management of immunotherapy-related adverse events
- Optimizing treatment for individual patients
Educational grants provided by Bristol-Myers Squibb and Pfizer |
8:00-10:00 (3) EADO & ICATMM SESSION
New strategies: from first results in metastatic melanoma to the application in the adjuvant therapy
Chairs: Sergio Chimenti (Italy),Alexander Eggermont (The Netherlands), Daniel Olive (France),Vernon Sondak (USA) |
| 8:00 |
Targeted therapies and combinations |
| 8:20 |
- Targeting mTOR
Friedegund Meier (Germany)
|
| 8:40 |
|
| 9:00 |
|
| 9:20 |
|
| 9:40 |
- Synthesis:What potential place in the palliative and adjuvant strategy?
(results of clinical trials)
Axel Hauschild (Germany)
|
10:30-11:10
(3) EADO & ICATMM SESSION
New strategies: from first results in metastatic melanoma to the application in the adjuvant therapy
Chairs: Caroline Robert (France), Martin A.Weinstock (USA) |
| 10:30 |
New development in chemotherapy and combinations
- Recent advances in chemotherapy and chemo-immunotherapy of melanoma
Sanjiv S.Agarwala (USA
|
| 10:50 |
- Combining chemotherapy and targeted therapy
Alessandro Testori (Italy)
|
11:10-12:30
FREE ORAL COMMUNICATIONS 2
Chairs: Helen Gogas (Greece), Roland Kaufmann (Germany), Paul Nathan (United Kingdom), Alessandro Testori (Italy) |
14:30-16:30
(3) EADO & ICATMM SESSION:
New strategies: from first results in metastatic melanoma to the application in the adjuvant therapy
Chairs: Charles Balch (USA), Claus Garbe (Germany), Jean-Jacques Grob (France) |
| 14:30 |
New development in immunotherapy and potential application in adjuvant setting
- Immune responses and melanoma
Daniel Olive (France)
|
| 14:50 |
- New approaches using cytokines
John M. Kirkwood (USA)
|
| 15:10 |
- Vaccination dendritic cells approach
Dirk Schadendorf (Germany)
|
| 15:30 |
- What’s new in adoptive immunotherapy
Brigitte Dreno (France)
|
| 15:50 |
- Anti CTLA4 and combination
Antoni Ribas (USA)
|
| 16:10 |
- Place of natural immunity modulation
Reinhard Dummer (Switzerland)
|
17:00-18:00
(3) EADO & ICATMM SESSION:
New strategies: from first results in metastatic melanoma to the application in the adjuvant therapy
Chairs: Keith Flaherty (USA),Axel Hauschild (Germany) |
| 17:00 |
New development in immunotherapy and potential application in adjuvant setting
- Using the sentinel lymph node as a target for adjuvant therapy
Tanja D. de Gruijl (The Netherlands)
|
| 17:20 |
- Synthesis:What potential place in the palliative and adjuvant strategy?
Caroline Robert (France)
|
| 17:40 |
- Systemic treatment of metastatic melanoma. Quo vadis oncologist?
Spyros Retsas (United Kingdom)
|
18:30-19:30
SATELLITE SYMPOSIUM sponsored by SCHERING-PLOUGH
Melanoma Care: From Retrospective to Perspective
Chair: Jean-Jacques Grob (France) |
| 18:30 |
- Opening Remarks
Jean-Jacques Grob (France)
|
| 18:35 |
- Succinct survey of new criteria for predicting risk in melanoma surgical patients: Update on AJCC staging
Charles Balch (USA)
|
| 18:45 |
- Adjuvant Interferon alpha for melanoma: Summary review of randomized trials
Axel Hauschild (Germany)
|
| 18:55 |
- EORTC 18991: Pegylated IFN vs observation in stage III melanoma: Overview of the role of tumor load and ulceration of primary melanoma
Alexander Eggermont (The Netherlands)
|
| 19:15 |
- Adjuvant therapy for melanoma:What are we waiting for?
Vernon Sondak (USA)
|
| 19:25 |
|
8:00-9:30
(4) EADO SESSSION
Chairs: Merrick Ross (USA), Dirk Schadendorf (Germany), Selma Ugurel (Germany) |
| 8:00 |
Non surgical treatments of non melanoma skin cancers (actinic keratoses, invasive squamous cell carcinoma and basal cell carcinoma)
- Is field cancerization more than a concept?
Eggert Stockfleth (Germany)
|
| 8:15 |
- Do we need to treat all actinic keratoses?
Martin A.Weinstock (USA
|
| 8:30 |
- Best indications of Solaraze
Hubert Pehamberger (Austria)
|
| 8:45 |
- Best indications of 5 FU
Eggert Stockfleth (Germany)
|
| 9:00 |
- Best indications of Imiquimod
Sergio Chimenti (Italy)
|
| 9:15 |
- What place for cryotherapy, PTD and laser in the treatment of actinic keratosis?
Marie-Aleth Richard (France)
|
9:30-10:00
FREE ORAL COMMUNICATIONS 3
Chairs: Merrick Ross (USA), Dirk Schadendorf (Germany), Selma Ugurel (Germany) |
10:30-11:00
(4) EADO SESSION
Chair: Susana Puig (Spain) |
| 10:30 |
Genetic counselling in melanoma
- The genetics of melanoma
Julia A. Newton-Bishop (United Kingdom)
|
| 10:45 |
- What practical impact of genetic counselling?
Ketty Peris (Italy)
|
11:00-12:30
(4) EADO SESSION
Chair: Julia A. Newton-Bishop (United Kingdom), Eggert Stockfleth (Germany) |
| 11:00 |
Managing cutaneous lymphoma
- Better understanding how to classify common and rare forms of skin lymphoma
Marie Beylot-Barry (France)
|
| 11:15 |
- Physiopathology of mycosis fungoides
Martine Bagot (France)
|
11:30 |
- Recent results in the treatment of mycosis fungoides
Reinhard Dummer (Switzerland)
|
| 11:45 |
- Refractory T cell skin lymphoma
Roland Kaufmann (Germany)
|
| 12:00 |
- Managing pseudo-lymphomas and low grades lymphomas
Hervé Bachelez (France)
|
| 12:15 |
- Managing Cutaneous Lymphoma
Réda Bouabdallah (France)
|
